Mode
Text Size
Log in / Sign up

Subclinical hypothyroidism does not significantly alter FSH, LH, estradiol, or total testosterone in PCOSThyroid Link To PCOS Hormones Looks Weak, Review Finds

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that subclinical hypothyroidism does not significantly alter primary reproductive hormones in patients with PCOS.

This meta-analysis evaluated the impact of subclinical hypothyroidism (SCH) on reproductive hormone levels in women with polycystic ovary syndrome (PCOS). The analysis included a total of 3,114 women, comparing those with SCH to euthyroid PCOS controls. The study aimed to determine if thyroid status influenced primary hormonal markers in this population.

The meta-analysis found no statistically significant differences in serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, or total testosterone between the two groups. A significant elevation in prolactin was observed, but the authors note this finding is exploratory and emerged only after the post-hoc exclusion of an outlying study.

Several limitations were noted, including high heterogeneity and the use of observational study designs, which preclude causal inferences. Additionally, the tests for prolactin, estradiol, and total testosterone were underpowered. The certainty of evidence is low for FSH and very low for LH, estradiol, prolactin, and total testosterone. These findings suggest that while SCH is present in some patients, it may not directly alter the primary reproductive hormone profile in PCOS.

How this fits prior evidence

This meta-analysis addresses the hormonal profile of women with PCOS, a condition where metabolic and hormonal markers are often altered. While prior evidence indicates that exercise and ketone supplementation can improve metabolic and hormonal profiles in PCOS, this study suggests that subclinical hypothyroidism specifically does not significantly impact FSH, LH, estradiol, or total testosterone. It adds to the understanding of how co-morbidities like thyroid dysfunction interact with PCOS-specific hormonal markers.

A new review looked at whether mild thyroid problems, called subclinical hypothyroidism, are linked to changes in reproductive hormones in women with polycystic ovary syndrome (PCOS). The review combined data from 3,114 women with PCOS. It compared women who had subclinical hypothyroidism with those who had normal thyroid function. The researchers looked at levels of several hormones, including FSH, LH, estradiol, prolactin, and total testosterone. They found no significant differences in FSH, LH, estradiol, or total testosterone. For prolactin, a possible increase appeared only after removing one unusual study, and the researchers call this finding exploratory. The review has important limits. It included observational studies, which cannot prove cause and effect. The studies were quite different from each other, and the tests for prolactin, estradiol, and total testosterone were underpowered, meaning they may have missed real differences. Certainty in the evidence was low for FSH and very low for the other hormones. No safety information was reported. For now, this review does not show a clear hormone link between mild thyroid problems and PCOS. Women with PCOS who have questions about thyroid testing or hormone levels should talk with their doctor.

What this means for you:
A review found no clear hormone link between mild thyroid problems and PCOS, though evidence is limited.

Common questions

What is subclinical hypothyroidism?

Subclinical hypothyroidism is a mild form of thyroid problems. In this review, it was studied in women with PCOS. The review compared their hormone levels with women who had normal thyroid function. It did not find significant differences in FSH, LH, estradiol, or total testosterone. If you have questions about your thyroid, talk with your doctor.

Did the review find any hormone changes?

The review found no significant differences in FSH, LH, estradiol, or total testosterone. For prolactin, a possible increase appeared only after removing one unusual study. The researchers call this finding exploratory. The evidence was low or very low certainty, so these results should not be taken as proof of a link.

How many women were included in this review?

The review included 3,114 women with polycystic ovary syndrome (PCOS). It compared women who had subclinical hypothyroidism with those who had normal thyroid function. The studies were observational, which means they cannot prove cause and effect. The review also noted high heterogeneity and underpowered tests for some hormones.

Should I be screened for thyroid problems if I have PCOS?

This review does not provide guidance on screening. It looked at hormone levels in women already diagnosed with subclinical hypothyroidism and PCOS. The evidence was limited and observational. Decisions about thyroid testing should be made with your doctor, based on your individual health and symptoms.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
ObjectiveThis systematic review and meta-analysis aimed to evaluate the effects of subclinical hypothyroidism (SCH) on serum levels of reproductive hormones, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin, and total testosterone, in women with polycystic ovary syndrome (PCOS) and to provide evidence for clinical practice.MethodsWe searched PubMed, Web of Science, Embase, and Cochrane Library from inception to 25 April 2026 for relevant observational studies. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Statistical analyses were performed using R software, with the standardized mean difference (SMD) and 95% confidence interval (CI) used as effect measures. Heterogeneity was evaluated using the I² statistic, followed by subgroup analysis, sensitivity analysis, and publication bias tests.ResultsThirteen studies involving 3,114 participants (579 PCOS patients with SCH and 2,535 euthyroid PCOS controls) were included. Pooled analyses showed no statistically significant differences in serum FSH, LH, estradiol, or total testosterone levels between groups. For prolactin, a significant elevation emerged after post-hoc exclusion of an outlying study contributing to extreme heterogeneity; this finding is exploratory. No significant publication bias was detected for FSH and LH; however, tests were underpowered for the other three outcomes, and Begg’s test suggested potential small-study effects for prolactin. Certainty according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework was low for FSH and very low for LH, estradiol, prolactin, and total testosterone.ConclusionCurrent evidence shows no significant differences in FSH, LH, estradiol, or total testosterone levels between SCH and euthyroid PCOS controls, while the evidence for prolactin remains uncertain. High heterogeneity and the observational study designs preclude definitive conclusions or causal inference.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261382326, identifier CRD420261382326.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.